Scott G. Ginn - Nov 21, 2022 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
EVP, CFO & Acting COO
Signature
/s/ Jennifer R. Guckert, pursuant to a power of attorney
Stock symbol
AMED
Transactions as of
Nov 21, 2022
Transactions value $
$0
Form type
4
Date filed
11/23/2022, 04:21 PM
Previous filing
Feb 22, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +23.1K +81.35% $0.00 51.5K Nov 21, 2022 Direct F1, F2
holding AMED Common Stock 2.71K Nov 21, 2022 Through 401(k) Plan F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 23,109 time-based restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 50% installments on each of November 21, 2025 and November 21, 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F2 The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
F3 The information in this report is based on a plan statement dated as of September 30, 2022.